 99 00 01 02
3.2
3.6
2.6
2.3
98
2.0
0.3
0.5
0.8
1.2
1.5
99 00 01 02
7.3
10.7
12.4
12.6
98
5.2
Highlights
Genetix Group plc
Annual Report and Accounts
Highlights
01
A year of progress despite tough market conditions
– Sustained profitability and cash generation
– Strategic investment in sales and marketing
– Continued focus and investment in R&D
– Prestigious LINK grant awarded for protein mapping research
– Cash balance of £20.9m (after share re-purchase of £1.4m)
Turnover (£m) Profit before tax (£m)
(excluding exceptionals and goodwill)
R&D expenditure
